Thus, the present study investigated whether CaN/NFATc3/EZH2 pathway plays a role in diabetic myocardial fibrosis, thereby presenting a new direction for prevention and treatment of myocardial fibrosis of diabetic patients. Here, NFATC3 is linked to Myocardial fibrosis.